Association between smoking and risk of bladder cancer among men and women
- PMID: 21846855
- PMCID: PMC3441175
- DOI: 10.1001/jama.2011.1142
Association between smoking and risk of bladder cancer among men and women
Erratum in
- JAMA. 2011 Nov 23;306(20):2220
Abstract
Context: Previous studies indicate that the population attributable risk (PAR) of bladder cancer for tobacco smoking is 50% to 65% in men and 20% to 30% in women and that current cigarette smoking triples bladder cancer risk relative to never smoking. During the last 30 years, incidence rates have remained stable in the United States in men (123.8 per 100,000 person-years to 142.2 per 100,000 person-years) and women (32.5 per 100,000 person-years to 33.2 per 100,000 person-years); however, changing smoking prevalence and cigarette composition warrant revisiting risk estimates for smoking and bladder cancer.
Objective: To evaluate the association between tobacco smoking and bladder cancer.
Design, setting, and participants: Men (n = 281,394) and women (n = 186,134) of the National Institutes of Health-AARP (NIH-AARP) Diet and Health Study cohort completed a lifestyle questionnaire and were followed up between October 25, 1995, and December 31, 2006. Previous prospective cohort studies of smoking and incident bladder cancer were identified by systematic review and relative risks were estimated from fixed-effects models with heterogeneity assessed by the I(2) statistic.
Main outcome measures: Hazard ratios (HRs), PARs, and number needed to harm (NNH).
Results: During 4,518,941 person-years of follow-up, incident bladder cancer occurred in 3896 men (144.0 per 100,000 person-years) and 627 women (34.5 per 100,000 person-years). Former smokers (119.8 per 100,000 person-years; HR, 2.22; 95% confidence interval [CI], 2.03-2.44; NNH, 1250) and current smokers (177.3 per 100,000 person-years; HR, 4.06; 95% CI, 3.66-4.50; NNH, 727) had higher risks of bladder cancer than never smokers (39.8 per 100,000 person-years). In contrast, the summary risk estimate for current smoking in 7 previous studies (initiated between 1963 and 1987) was 2.94 (95% CI, 2.45-3.54; I(2) = 0.0%). The PAR for ever smoking in our study was 0.50 (95% CI, 0.45-0.54) in men and 0.52 (95% CI, 0.45-0.59) in women.
Conclusion: Compared with a pooled estimate of US data from cohorts initiated between 1963 and 1987, relative risks for smoking in the more recent NIH-AARP Diet and Health Study cohort were higher, with PARs for women comparable with those for men.
Comment in
-
Tobacco smoking and bladder cancer.JAMA. 2011 Nov 23;306(20):2216-7; author reply 2217. doi: 10.1001/jama.2011.1717. JAMA. 2011. PMID: 22110102 No abstract available.
Similar articles
-
Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study.Lancet Oncol. 2008 Jul;9(7):649-56. doi: 10.1016/S1470-2045(08)70154-2. Epub 2008 Jun 13. Lancet Oncol. 2008. PMID: 18556244 Free PMC article.
-
Association between long-term low-intensity cigarette smoking and incidence of smoking-related cancer in the national institutes of health-AARP cohort.Int J Cancer. 2018 Jan 15;142(2):271-280. doi: 10.1002/ijc.31059. Epub 2017 Oct 10. Int J Cancer. 2018. PMID: 28929489 Free PMC article.
-
Prospective investigation of the cigarette smoking-head and neck cancer association by sex.Cancer. 2007 Oct 1;110(7):1593-601. doi: 10.1002/cncr.22957. Cancer. 2007. PMID: 17724671
-
Cigarette smoking and bladder cancer risk: an evaluation based on a systematic review of epidemiologic evidence in the Japanese population.Jpn J Clin Oncol. 2016 Mar;46(3):273-83. doi: 10.1093/jjco/hyv188. Epub 2016 Jan 17. Jpn J Clin Oncol. 2016. PMID: 26941372 Review.
-
Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis.Am J Epidemiol. 2011 Apr 1;173(7):721-30. doi: 10.1093/aje/kwq437. Epub 2011 Mar 2. Am J Epidemiol. 2011. PMID: 21367875 Free PMC article. Review.
Cited by
-
Prediction of recurrence risk in patients with non-muscle-invasive bladder cancer.Asian J Urol. 2024 Oct;11(4):625-632. doi: 10.1016/j.ajur.2023.04.007. Epub 2024 Feb 23. Asian J Urol. 2024. PMID: 39533991 Free PMC article.
-
Downregulation of the keratins CK13 and CK14 does not significantly affect cell viability of human urinary bladder carcinoma cells.Contemp Oncol (Pozn). 2024;28(3):227-234. doi: 10.5114/wo.2024.144215. Epub 2024 Oct 15. Contemp Oncol (Pozn). 2024. PMID: 39512531 Free PMC article.
-
Molecular Landscape of Bladder Cancer: Key Genes, Transcription Factors, and Drug Interactions.Int J Mol Sci. 2024 Oct 12;25(20):10997. doi: 10.3390/ijms252010997. Int J Mol Sci. 2024. PMID: 39456780 Free PMC article.
-
Passive smoking and risk of pancreatic cancer: an updated systematic review and meta-analysis.PeerJ. 2024 Oct 8;12:e18017. doi: 10.7717/peerj.18017. eCollection 2024. PeerJ. 2024. PMID: 39399427 Free PMC article.
-
Bladder transitional cell carcinoma anatomic primary site as a predictor of survival and mortality: a population-based retrospective cohort study.Ann Med Surg (Lond). 2024 Sep 18;86(10):5716-5723. doi: 10.1097/MS9.0000000000002581. eCollection 2024 Oct. Ann Med Surg (Lond). 2024. PMID: 39359812 Free PMC article.
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108. - PubMed
-
- Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300. - PubMed
-
- Fast Stats: An interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute. 2011 Nov 7; http://seer.cancer.gov/faststats.;
-
- Silverman DT, Devesa SS, Moore LE, Rothman N. Bladder Cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer Epidemiology and Prevention. Third ed. New York, New York: Oxford University Press; 2006. pp. 1101–1127.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
